Population
Patients with congenital von Willebrand disease (VWD) and acquired von Willebrand syndrome (AVWS)
Design
Review
Authors
Loading...
VWF replacement remains first-line for VWD/AVWS bleeding prevention; leaves open optimal regimens and non-replacement strategies.
This review summarizes current standard-of-care treatments for von Willebrand disease, highlighting the primary role of VWF and FVIII replacement therapies to prevent bleeding.
Pasalic et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: